New to Moneycontrol - Sign up now
Its easy and FREE!
OR connect with
connect with
Don’t have an account?
Create One
28th-May-2012 14:44Source: BSE
Ranbaxy Labs - Ranbaxy Announces USFDA approval of CIP-ISOTRETINOIN NDA
Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated May 28, 2012 titled "Ranbaxy Announces USFDA approval of CIP-ISOTRETINOIN NDA".
More Announcements on:
20th-Jun-2013 10:02Source: NSE
Ranbaxy Laboratories Limited
20th-Jun-2013 09:57Source: BSE
Ranbaxy Labs - Decision of European Commission
31st-May-2013 14:26Source: NSE
31st-May-2013 12:27Source: BSE
Ranbaxy Labs - Press Statement
22nd-May-2013 16:36Source: NSE
22nd-May-2013 15:49Source: BSE
Ranbaxy Labs - Ranbaxy Highlights Improved Business and Quality Assurance Standards - Dedicated to Providing Safe and Efficacious Medicines Globally
14th-May-2013 12:20Source: BSE
Ranbaxy Labs - Ranbaxy announces conclusion of previously disclosed investigation by U.S. Department of Justice
14th-May-2013 08:46Source: NSE
9th-May-2013 11:04Source: NSE
9th-May-2013 10:45Source: BSE
Ranbaxy Labs - Disclosure of Voting results of AGM (Clause 35A)
Login to moneycontrol.com
Existing Members, Login
Keep me signed in
Forgot Password?
Live: Over 1,000 people brought to Guptkashi from Kedarnath
NSE: RANBAXY
Source: 
